Stockreport

Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial

Vaxart, Inc.  (VXRT) 
Last vaxart, inc. earnings: 3/19 04:01 pm Check Earnings Report
PDF SOUTH SAN FRANCISCO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing a range of oral recombina [Read more]